News
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)
Telomir Pharmaceuticals, Inc. announces groundbreaking results in preclinical studies for AMD treatment, showcasing Telomir-1's ability to reverse oxidative damage in retinal cells -
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses
Telomir Pharmaceuticals, Inc. announces groundbreaking results in reversing oxidative stress challenges and cellular protection. Telomir-1 shows promise in addressing age-related diseases and viral infections -
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)
Telomir Pharmaceuticals announces potentially groundbreaking findings from preclinical progeria lifespan study demonstrating restoration of shortened lifespan and normalization of accelerated aging with Telomir-1 -
-
